XML 39 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 270,918 $ 142,845 $ 108,201
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 68,410 57,403 52,066
Amortization of debt issuance costs and non-cash interest 1,146 1,727 2,136
Gain on disposal of property and equipment (3,473) (5,286) (2,637)
Gain on deconsolidation of subsidiary, net (91,289) 0 0
Gain on debt extinguishment, net 0 0 (2,428)
Gain on disposition of Myers 0 0 (16,687)
Deferred taxes 32,573 14,746 36,492
Stock-based compensation 19,003 14,622 12,726
Change in fair value of interest rate swap 0 0 (203)
Changes in operating assets and liabilities (Note 18) 199,816 252,527 29,450
Net cash provided by operating activities 497,104 478,584 219,116
Cash flows from investing activities:      
Acquisitions, net of cash acquired (11,223) (51,177) (18,004)
Disposition, net of cash disposed 0 14,000 (15,789)
Deconsolidation, net of cash (103,829) 0 0
Capital expenditures (80,954) (64,379) (60,909)
Proceeds from sale of property and equipment 10,157 13,804 4,947
Net cash used in investing activities (185,849) (87,752) (89,755)
Cash flows from financing activities:      
Cash received from credit facility 0 2,562 0
Repayments of debt (26,539) (93,491) (23,373)
Repurchase of common stock (70,596) 0 0
Distributions to noncontrolling interest owners 0 (2,450) 0
Withholding taxes paid on net share settlement of equity awards (21,452) (9,567) (9,416)
Debt issuance costs 0 (1,572) 0
Other (36) (16) 0
Net cash used in financing activities (118,623) (104,534) (32,789)
Net change in cash, cash equivalents, and restricted cash 192,632 286,298 96,572
Cash, cash equivalents and restricted cash at beginning of period 471,563 185,265 88,693
Cash, cash equivalents and restricted cash at end of period 664,195 471,563 185,265
Less: restricted cash - Continuing Operations 0 0 (3,721)
Cash and cash equivalents at end of period - Continuing Operations 664,195 471,563 181,544
Supplemental disclosures of cash flow information:      
Cash paid during the period for interest 23,383 27,011 19,322
Cash paid during the period for income taxes 53,072 36,906 5,602
Non-cash items:      
Share consideration given for acquisitions 1,000 0 4,851
Deferred payments from buyer of Myers 0 0 18,000
Capital expenditures $ 1,868 $ 12,506 $ 1,925